Syndax Pharmaceuticals SNDX Collaboration Receivable Net
Collaboration Receivable Net at other companies
Other financials
Where this comes from
Reported directly by Syndax Pharmaceuticals in its filing.
Tagged under the XBRL concept sndx:CollaborationReceivableNet.
The official record: Syndax Pharmaceuticals’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Syndax Pharmaceuticals's collaboration receivable net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Syndax Pharmaceuticals's collaboration receivable net?
- Syndax Pharmaceuticals (SNDX) reported collaboration receivable net of $20.51M in Q1 2026.
- What does collaboration receivable net mean?
- This represents the net amount due to the company from collaborative partners for research, development, or commercialization activities expected to be collected within one year. It serves as a key indicator of the company's ability to monetize its intellectual property and R&D partnerships. A growing balance often signals successful milestone achievement or effective cost-sharing arrangements with strategic partners.